Perrigo
As on 02 Jul, 2025 | 01:29 IST
| Open | 26.54 |
| Previous Close | 26.71 |
| Beta | 0.24 |
| High | 27.88 |
| Low | 26.33 |
| TTM EPS See historical trend | 2.87(+18.60% YoY) |
| 52 Week High | 30.91 |
| 52 Week Low | 23.14 |
| TTM PE See historical trend | 9.56(Low PE) |
| Mkt. Cap ($ Billion) | 3.72 |
| Dividend Yield | 4.14 |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 26.79 |
| 10 | 26.63 |
| 20 | 26.66 |
| 50 | 26.35 |
| 100 | 26.38 |
| 200 | 26.27 |
Returns
| 1 Week | 3.78% | |
| 1 Month | 2.35% | |
| 3 Months | -2.24% | |
| YTD | 6.81% | |
| 1 Year | 6.87% | |
| 3 Years | -32.36% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | 1,004.01 | -0.37 | 954.58 | 41.47 | 24.21 | 0.58 | 1,133.95/623.99 | -3.29 | Very Bearish |
| J&J | 245.03 | -0.70 | 590.47 | 22.69 | 10.80 | 2.50 | 251.71/143.68 | 9.15 | Very Bullish |
| AbbVie | 235.73 | 0.80 | 416.57 | 23.57 | 10.00 | 2.91 | 244.80/164.59 | 5.27 | Bearish |
| Merck | 120.55 | 0.60 | 305.31 | 13.44 | 8.97 | 3.12 | 125.14/73.35 | 11.72 | Bearish |
| Abbott | 113.46 | -0.13 | 196.79 | 22.03 | 5.15 | 1.92 | 139.14/105.28 | 4.86 | Very Bearish |
Market news
- S&P 500 ends up slightly as tech dips, inflation coolsFebruary 14, 2026 9:22 AM
- Dow Jones Industrial Average breaks 50,000 level for first timeFebruary 7, 2026 9:16 AM
- US stocks fall, as investors fret over Trump's Fed nominee, earnings, inflationJanuary 31, 2026 8:34 AM
- Dow ends lower after topsy-turvy week, as Intel's outlook weighs on market sentimentJanuary 24, 2026 8:43 AM
About the company
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.